NewGenIvf (NIVF) Net Income towards Common Stockholders (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Net Income towards Common Stockholders of -$7.7 million for Q4 2025, down 1322.06% year-over-year from $631498.7 in Q4 2024, and down 145.87% quarter-over-quarter from $16.8 million in Q3 2025.

NewGenIvf (NIVF) Net Income towards Common Stockholders (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has reported Net Income towards Common Stockholders for 2 consecutive years, with -$7.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Net Income towards Common Stockholders fell 1322.06% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at $8.6 million (up 1622.27% YoY), while the FY2025 annual figure was $8.0 million, up 1062.8% from the prior year.
  • Net Income towards Common Stockholders retreated to -$7.7 million in Q4 2025 per NIVF's latest filing, from $16.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $16.8 million in Q3 2025 and bottomed at -$7.7 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 1.93 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 826.00 Mn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn -600,000.00
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 343.22 Mn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn 99.83 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn 358.45 Mn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn 76.35 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 67.70 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn 67.30 Mn
10 NewGenIvf 9,048.24 -1.43 Mn 524,025.00 -7.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.72 Mn
Sep 30, 2025 16.82 Mn
Dec 31, 2024 -542,684.00
Sep 30, 2024 -19,857.00